In vivo evaluation of the synthesized novel 2-benzyloxybenzaldehyde analog CCY-1a-E2 for the treatment of leukemia in the BALB/c mouse WEHI-3 allograft model. | Oncol Lett;5(3): 777-782, 2013 Mar. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

In vivo evaluation of the synthesized novel 2-benzyloxybenzaldehyde analog CCY-1a-E2 for the treatment of leukemia in the BALB/c mouse WEHI-3 allograft model.

Lin, Chingju; Yang, Jai-Sing; Tsai, Shih-Chang; Lin, Chin-Fen; Lee, Miau-Rong.

Affiliation

Lin C; Departments of Physiology, China Medical University, Taichung 40402, Taiwan, R.O.C.

Oncol Lett ; 5(3): 777-782, 2013 Mar.

Article in En | MEDLINE | ID: mdl-23426190

Key words

2-benzyloxybenzaldehyde; BALB/c mouse WEHI-3 allograft model; CCY-1a-E2; leukemia WEHI-3 cells; safety evaluation

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncol Lett Year: 2013 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncol Lett Year: 2013 Document type: Article